Tuesday, April 12, 2016

CORRECTED-UPDATE 1-FDA panel votes against quick approval for Clovis cancer drug

April 12 (Reuters) - An independent panel of experts

advising the U.S. Food and Drug Administration did not back the

accelerated approval of Clovis Oncology Inc's lung

cancer drug.

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)